Morgan Leigh 4
4 · Kymera Therapeutics, Inc. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Morgan Leigh
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-18+16,000→ 16,000 totalExercise: $31.20Exp: 2034-06-17→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 18, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders.